Top Markets
#1 MowCat MowCat +48.91%
#2 Velvet Velvet +26.35%
#3 Bermuda Shorts Bermuda Shorts +24.91%
#4 Biconomy Biconomy +20.63%
#5 Derive Derive +20.62%
#6 Quack AI Quack AI +19.12%
#7 Audiera Audiera +18.88%
#8 aPriori aPriori +18.67%
#9 Geodnet Geodnet +11.70%
#10 DUSK Network DUSK Network +9.97%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
ANG Lifesciences India Limited ANG Lifesciences India Limited

ANG Lifesciences India Limited

ANG
Clasificación en acciones #35050
ANG Lifesciences India Ltd. specializes in the creation and distribution of... ANG Lifesciences India Ltd. specializes in the creation and distribution of finished pharmaceutical products, specifically sterile dry powder intended for injection vials. The company's diverse product line includes sterile dry powder vials for treatments such as antibiotics, anti-ulcer medications, glucocorticoids, anti-inflammatory agents, anti-malarial drugs, and anesthetics. Rajesh Gupta founded the company on June 14, 2006, and its main corporate office is situated in Amritsar, India.
Precio por acción
$0.34674726
Última sincronización: 2026-08-14
Capitalización bursátil
$4.53M
Cambio (1 día)
0.00%
Cambio (1 año)
6.69%
País
IN
Comercio ANG Lifesciences India Limited (ANG)

Categoría

Healthcare
Ganancias de ANG Lifesciences India Limited (ANG)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di ANG Lifesciences India Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de ANG Lifesciences India Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US